About us
Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers and localized infectious diseases. We are dedicated to fostering the development of chemotherapeutic s based on the technology platform, utilizing molecular photoswitches. As a university Spin-off we perform rigorous science translating into societal benefit.
Management team
![](/images/Tim_Schober.png)
Dr Tim Schober
Co-founder
CEO
CEO
![Kateryna Tolmachova](/images/Kateryna_Tolmachova.png)
Kateryna Tolmachova
Co-founder
![](/images/Sergii_Afonin.png)
Dr Sergii Afonin
Co-founder
COO
COO
Scientific advisors
![](/images/Igor_Komarov.png)
Prof Igor Komarov
Co-founder
Scientific advisor
Scientific advisor
![](/images/Oleg_Babii.png)
Dr Oleg Babii
Co-founder
Scientific advisor
Scientific advisor
External advisors
Immuno-oncology discovery program is being implemented under scientific advise of Prof Viktor Umansky (German Cancer Research Center (DKFZ), Heidelberg, Germany)